67th iCeMS Seminar: Assoc. Prof. Insoo Hyun

The ethical issues surrounding the use of iPS cell-based drug discovery systems are derived from the notion of moral complicity. Regardless of one's views about the moral status of preimplantation human embryos, it is argued that researchers and other beneficiaries of this technology must think seriously about two possible sources of their moral complicity — embryo destruction and injustices to the original somatic cell donor.

Lecturer	Assoc. Prof. Insoo Hyun Department of Bioethics Case Western Reserve University School of Medicine
Title	The Bioethics of iPS Cell-Based Drug Discovery
Date / Time	January 28, 2011 / 10:30–12:00
Venue	2nd floor Seminar Room (#A207), Main Building iCeMS Complex 1, Kyoto University Directions
Flyer	PDF (408KB)
Hosts	Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University Tadashi Kobayashi, A Platform for Creating New Wisdom on Life, Joint Research Center, Institute for Research in Humanities , Kyoto University Ryuichi Ida, Ethical governance for research in frontier medical and life sciences, Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (B)
Contact	iCeMS Adj. Assoc. Prof. Kazuo Kato kato-g@icems.kyoto-u.ac.jp